POTED
POTE ankyrin domain family member D
Also known as: A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21, POTED_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86YR6
- Gene
- POTED
- Ensembl
- ENSG00000166351
- Chromosome
- 21
- Canonical length
- 584 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
584 residues, UniProt reviewed canonical sequence.
>Q86YR6|POTED
1 MVAEVCSMPT ASTVKKPFDL RSKMGKWCHH RFPCCRGSGK SNMGTSGDHD DSFMKMLRSK
61 MGKCCRHCFP CCRGSGTSNV GTSGDHENSF MKMLRSKMGK WCCHCFPCCR GSGKSNVGAW
121 GDYDHSAFME PRYHIRREDL DKLHRAAWWG KVPRKDLIVM LRDTDMNKRD KEKRTALHLA
181 SANGNSEVVQ LLLDRRCQLN VLDNKKRTAL IKAIQCQEDE CVLMLLEHGA DRNIPDEYGN
241 TALHYAIYNE DKLMAKALLL YGADIESKNK CGLTPLLLGV HEQKQQVVKF LIKKKANLNV
301 LDRYGRTALI LAVCCGSASI VNLLLEQNVD VSSQDLSGQT AREYAVSSHH HVICELLSDY
361 KEKQMLKISS ENSNPEQDLK LTSEEESQRL KVSENSQPEK MSQEPEINKD CDREVEEEIK
421 KHGSNPVGLP ENLTNGASAG NGDDGLIPQR RSRKPENQQF PDTENEEYHS DEQNDTRKQL
481 SEEQNTGISQ DEILTNKQKQ IEVAEQKMNS ELSLSHKKEE DLLRENSVLQ EEIAMLRLEL
541 DETKHQNQLR ENKILEEIES VKEKTDKLLR AMQLNEEALT KTNILocalizationUniProt · AlphaFold · HPA
Whether an antibody against POTED can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 2.8 nTPM
Expression across tissuesHPA
Tissue
- testis: 2.8 nTPM
- retina: 0.2 nTPM
- thyroid gland: 0.2 nTPM
- adipose tissue: 0.1 nTPM
- adrenal gland: 0.1 nTPM
- heart muscle: 0.1 nTPM
Single-cell type
- early primary spermatocytes: 2.9 nCPM
- undifferentiated spermatogonia: 2.5 nCPM
- late primary spermatocytes: 1.5 nCPM
- differentiating spermatogonia: 1.2 nCPM
- late spermatids: 0.7 nCPM
- prostatic hillock cells: 0.6 nCPM
Immune cell
- basophil: 0.3 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 1.5 nTPM
- cerebral cortex: 1.4 nTPM
- hypothalamus: 1.4 nTPM
- medulla oblongata: 1.3 nTPM
- midbrain: 1.3 nTPM
- amygdala: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POTED as an antibody target. Whether an autoantibody or antibody against POTED could matter depends on whether native POTED is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POTED is annotated at the cell surface, where native POTED is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label POTED as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...